2015
DOI: 10.1001/jamaophthalmol.2015.2852
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Effect and Corneal Light Scattering With 2 Corneal Cross-linking Protocols

Abstract: IMPORTANCE We describe and evaluate a complementary method to indirectly quantify the treatment effect of corneal cross-linking (CXL). Additional methods to indirectly quantify the treatment effect of CXL are needed. OBJECTIVE To assess the spatial distribution and the time course of the increased corneal densitometry (corneal light backscatter) seen after CXL with riboflavin and UV-A irradiation. DESIGN, SETTING, AND PARTICIPANTS Open-label randomized clinical trial of 43 patients (60 eyes) who were 18 to 28 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
6
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 31 publications
3
6
0
Order By: Relevance
“…On the contrary, a symmetrical treatment pattern (CXL in the present study) also gives a symmetrical treatment effect. In accordance with our previous reports,15 18 this study shows that the increase in corneal densitometry relates to the CXL treatment effect, which is in alignment with recent in vivo confocal microscopy findings, where the phenomenon of light scattering is explained as an ‘indirect sign of CXL-induced stromal collagen compaction and remodeling’ 19. Accordingly, with an asymmetrical treatment pattern as in the present study, an increase in corneal densitometry is seen only where the cornea is crosslinked, but not outside the treatment zone.…”
Section: Discussionsupporting
confidence: 94%
See 2 more Smart Citations
“…On the contrary, a symmetrical treatment pattern (CXL in the present study) also gives a symmetrical treatment effect. In accordance with our previous reports,15 18 this study shows that the increase in corneal densitometry relates to the CXL treatment effect, which is in alignment with recent in vivo confocal microscopy findings, where the phenomenon of light scattering is explained as an ‘indirect sign of CXL-induced stromal collagen compaction and remodeling’ 19. Accordingly, with an asymmetrical treatment pattern as in the present study, an increase in corneal densitometry is seen only where the cornea is crosslinked, but not outside the treatment zone.…”
Section: Discussionsupporting
confidence: 94%
“…Inclusion required a diagnosis of progressive keratoconus with a minimum corneal thickness of 400 µm at the thinnest point after epithelial removal. The keratoconus diagnosis was based on the Amsler-Krumeich grading14 and the ‘Total Deviation’ keratoconus quantification value from the ‘Belin-Ambrosio enhanced ectasia’ measurements of the Pentacam HR, plus an altered red reflex and/or distortion of the keratometric mires 13 15. Disease progression was verified by increasing corneal steepness (increase in K max of ≥1 D in 1 year) and/or thinning of the cornea on repeated Scheimpflug tomography measurements in 41 eyes; in 9 eyes, the progression was verified by increasing keratometric astigmatism and corneal steepness and decreasing best-spectacle-corrected visual acuity.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The depths were noticeably deep for both protocols, as they probably better correlate with the degree of early postoperative haze, glare and light scattering, which likely goes beyond the area of the morphological changes of the keratocytes. Nevertheless, the light scattering can be used for comparing our two treatment protocols, and one possible explanation to the deeper light scattering for the homogenous protocol might be that the illumination at a given fluence will be higher at the corneal centre because of the corneal curvature (Rehnman et al 2015).…”
Section: Discussionmentioning
confidence: 99%
“…e conservative treatment modalities, such as spectacles and gas permeable rigid contact lenses, become insufficient for visual rehabilitation in the advanced stages of KC, and 10-20% of patients need corneal transplantation [3]. Wollensak et al [5] introduced the CXL treatment in 2003, which is being considered a standard, minimally invasive, and safe therapeutic option for progressive KC [5][6][7][8][9][10][11][12][13][14][15][16][17][18]. e principle goal of CXL is to stabilize the progression of KC by increasing the mechanical stability of the cornea [4][5][6][7][8][9][10][11][12][13][14][15][16][17][18].…”
Section: Introductionmentioning
confidence: 99%